Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
A California jury has awarded $292.5 million in actual and punitive damages to Guardant Health in a false advertising lawsuit against Natera. The jury found that Natera falsely claimed its colorectal cancer test, Signatera, was superior to Guardant's competing product, Reveal. Natera has issued a statement regarding the litigation, although details of the statement were not disclosed. This ruling marks a significant legal setback for Natera amid ongoing competition in the medical testing market.
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium $NTRA https://t.co/kpAHpYoSTX
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC) https://t.co/mNj0BFVyWg https://t.co/3tYxJTQpLe
Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update https://t.co/QjOULXanGV https://t.co/CD7fBi6CzI
